Number of the records: 1
Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis
SYS 0182977 LBL 00000naa--2200000-a-4500 005 20250607175039.5 008 220912s2022----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis / $c Wei-Ya Yan ... [et al.] 300 $b ilustr., grafy, obr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d002289 $a karcinóm pľúc, nemalobunkový $x terapia $2 mesh 650 22
$7 sllk_us_auth*d000077156 $a gefitinib $x použitie terapeutické $2 mesh 650 22
$7 sllk_us_auth*d004359 $a farmakoterapia kombinovaná $2 mesh 650 22
$7 sllk_us_auth*d000079403 $a feroptóza $2 mesh 650 22
$7 sllk_us_auth*d045744 $a línia bunková nádorová $2 mesh 650 22
$7 sllk_us_auth*d008819 $a myši nahé $2 mesh 653 2-
$a betulín 653 2-
$a kombinácia betulín a gefitinib 653 2-
$a štúdia experimentálna 700 1-
$7 sllk_us_auth*0056548 $a Yan, Wei-Ya $4 aut 773 0-
$7 nnas $w sllk_us_cat*0182714 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2022 $g Vol. 69, no. 3 (2022), s. 648-656
Number of the records: 1